Skip to main content
. Author manuscript; available in PMC: 2010 Sep 6.
Published in final edited form as: Drug Discov Today. 2009 Sep 24;14(23-24):1089–1097. doi: 10.1016/j.drudis.2009.09.003

FIGURE 4.

FIGURE 4

Prodrug strategies. (a) Example of a photoactivatable octahedral RhIII complex with an extended diimine ligand. (b) Satraplatin. (c) Example of a photoactivatable trans-azido platinum(IV) prodrug. (d) Ferrocifen. (e) Cobalt-marimastat bioconjugate. (f) RuII arene complexes containing iodo and phenylplazopyridine ligand. (g) RuII arene complexes containing a thiolate ligand. (h) Pt(IV)-estradiol bioconjugate. (i) Ethacraplatin.